Enovix Corporation (ENVX) concluded trading on Wednesday at a closing price of $11.19, with 11.1 million shares of worth about $124.2 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 14.07% during that period and on February 19, 2025 the price saw a gain of about 0.27%. Currently the company’s common shares owned by public are about 177.59M shares, out of which, 159.85M shares are available for trading.
Stock saw a price change of 5.87% in past 5 days and over the past one month there was a price change of 4.38%. Year-to-date (YTD), ENVX shares are showing a performance of 2.94% which decreased to -4.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.70 but also hit the highest price of $18.68 during that period. The average intraday trading volume for Enovix Corporation shares is 6.10 million. The stock is currently trading -3.32% below its 20-day simple moving average (SMA20), while that difference is up 2.61% for SMA50 and it goes to 0.89% higher than SMA200.
Enovix Corporation (NASDAQ: ENVX) currently have 177.59M outstanding shares and institutions hold larger chunk of about 49.06% of that.
The stock has a current market capitalization of $2.11B and its 3Y-monthly beta is at 1.86. It has posted earnings per share of -$1.62 in the same period. It has Quick Ratio of 3.61 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENVX, volatility over the week remained 6.55% while standing at 7.62% over the month.
Stock’s fiscal year EPS is expected to rise by 13.97% while it is estimated to increase by 21.58% in next year.
Coverage by The Benchmark Company stated Enovix Corporation (ENVX) stock as a Buy in their note to investors on July 22, 2024, suggesting a price target of $25 for the stock. On December 18, 2023, William Blair Initiated their recommendations, while on July 21, 2023, TD Cowen Downgrade their ratings for the stock with a price target of $20. Stock get a Buy rating from Canaccord Genuity on January 11, 2023.
